Extreme Blood Pressure Fluctuations in a Patient with Intact Autonom Ic Reflexes a Nd Intact Sod Iu M Conservation 1
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Control Study of Pregnancy Complications and Birth Outcomes
Hypertension Research (2011) 34, 55–61 & 2011 The Japanese Society of Hypertension All rights reserved 0916-9636/11 $32.00 www.nature.com/hr ORIGINAL ARTICLE Hypotension in pregnant women: a population-based case–control study of pregnancy complications and birth outcomes Ferenc Ba´nhidy1,Na´ndor A´ cs1, Erzse´bet H Puho´ 2 and Andrew E Czeizel2 Hypotension is frequent in pregnant women; nevertheless, its association with pregnancy complications and birth outcomes has not been investigated. Thus, the aim of this study was to analyze the possible association of hypotension in pregnant women with pregnancy complications and with the risk for preterm birth, low birthweight and different congenital abnormalities (CAs) in the children of these mothers in the population-based data set of the Hungarian Case–Control Surveillance of CAs, 1980–1996. Prospectively and medically recorded hypotension was evaluated in 537 pregnant women who later had offspring with CAs (case group) and 1268 pregnant women with hypotension who later delivered newborn infants without CAs (control group); controls were matched to sex and birth week of cases (in the year when cases were born), in addition to residence of mothers. Over half of the pregnant women who had chronic hypotension were treated with pholedrine or ephedrine. Maternal hypotension is protective against preeclampsia; however, hypotensive pregnant women were at higher risk for severe nausea or vomiting, threatened abortion (hemorrhage in early pregnancy) and for anemia. There was no clinically important difference in the rate of preterm births and low birthweight newborns in pregnant women with or without hypotension. The comparison of the rate of maternal hypotension in cases with 23 different CAs and their matched controls did not show a higher risk for CAs (adjusted OR with 95% confidence intervals: 0.66, 0.49–0.84). -
Definitions • Septic Shock
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Ann Rheum Dis Definitions • Septic shock: Persisting hypotension despite volume resuscitation, requiring vasopressors to maintain mean artery pressure (MAP) ≥65 mmHg and serum lactate level >2 mmol/L (1). • Renal failure: Doubling of basal Creatinine value or urine output <0.5 ml/kg/h for ≥12h (2) • Heart failure: Gradual or rapid change in heart failure signs and symptoms resulting in a need for urgent therapy (3). • Myocarditis: Myocarditis was diagnosed if serum levels of high-sensitivity cardiac troponin I were above the 99th percentile upper reference limit and compatible abnormalities were shown in electrocardiography and echocardiography. • Encephalopathy: Impaired consciousness as change of consciousness level (somnolence, stupor, and coma) or consciousness content (confusion and delirium) (4). • Thrombosis: Clinically or by imaging diagnosed acute pulmonary embolism (PE), deep-vein thrombosis, ischemic stroke, myocardial infarction or systemic arterial embolism (5). References 1. World Health Organization. Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection- when-novel-coronavirus-(ncov)-infection-is-suspected. 2. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179-84. 10.1159/000339789. 3. Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112(25):3958-3968. 4. Mao L, Jin H, Wang M, et al. -
Hypertension: Putting the Pressure on the Silent Killer
HYPERTENSION: PUTTING THE PRESSURE ON THE SILENT KILLER MAY 2016 TABLEHypertension: putting OF the CONTENTS pressure on the silent killer Table of contents UNDERSTANDING HYPERTENSION AND THE LINK TO CARDIOVASCULAR DISEASE 2 Understanding hypertension and the link to cardiovascular disease THEThe social SOCIAL and economic AND impact ECONOMIC of hypertension IMPACT OF HYPERTENSION 3 Diagnosing and treating hypertension – what is out there? DIAGNOSINGChallenges to tackling hypertension AND TREATING HYPERTENSION – WHAT IS OUT THERE? 6 Opportunities and focus areas for policymakers CHALLENGES TO TACKLING HYPERTENSION 9 OPPORTUNITIES AND FOCUS AREAS FOR POLICYMAKERS 15 HYPERTENSION: PUTTING THE PRESSURE ON THE SILENT KILLER UNDERSTANDING HYPERTENSION AND THE LINK TO CARDIOVASCULAR DISEASE Cardiovascular disease (CVD), or heart disease, is the number one cause of death in the world. 80% of deaths due to CVD occur in countries and poor communities where health systems are weak, and CVD accounts for nearly half of the estimated US$500 billion annual lost economic output associated with noncommunicable diseases (NCDs) in low-income and middle-income countries. In 2012, CVD killed 17.5 million people – the equivalent of every 3 in 10 deaths.1 Of these 17 million deaths a year, over half – 9.4 million - are caused by complications in hypertension, also commonly referred to as raised or high blood pressure2. Hypertension is a risk factor for coronary heart disease and the single most important risk factor for stroke - it is responsible for at least 45% of deaths due to heart disease, and at least 51% of deaths due to stroke. High blood pressure is defined as a systolic blood pressure at or above 140 mmHg and/or a diastolic blood pressure at or above 90 mmHg. -
Hypertension and Coronary Heart Disease
Journal of Human Hypertension (2002) 16 (Suppl 1), S61–S63 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh Hypertension and coronary heart disease E Escobar University of Chile, Santiago, Chile The association of hypertension and coronary heart atherosclerosis, damage of arterial territories other than disease is a frequent one. There are several patho- the coronary one, and of the extension and severity of physiologic mechanisms which link both diseases. coronary artery involvement. It is important to empha- Hypertension induces endothelial dysfunction, exacer- sise that complications and mortality of patients suffer- bates the atherosclerotic process and it contributes to ing a myocardial infarction are greater in hypertensive make the atherosclerotic plaque more unstable. Left patients. Treatment should be aimed to achieve optimal ventricular hypertrophy, which is the usual complication values of blood pressure, and all the strategies to treat of hypertension, promotes a decrease of ‘coronary coronary heart disease should be considered on an indi- reserve’ and increases myocardial oxygen demand, vidual basis. both mechanisms contributing to myocardial ischaemia. Journal of Human Hypertension (2002) 16 (Suppl 1), S61– From a clinical point of view hypertensive patients S63. DOI: 10.1038/sj/jhh/1001345 should have a complete evaluation of risk factors for Keywords: hypertension; hypertrophy; coronary heart disease There is a strong and frequent association between arterial hypertension.8 Hypertension is frequently arterial hypertension and coronary heart disease associated to metabolic disorders, such as insulin (CHD). In the PROCAM study, in men between 40 resistance with hyperinsulinaemia and dyslipidae- and 66 years of age, the prevalence of hypertension mia, which are additional risk factors of atheroscler- in patients who had a myocardial infarction was osis.9 14/1000 men in a follow-up of 4 years. -
Hypertension, Cholesterol, and Aspirin with Cost Info
Diabetes & Your Health High Blood Pressure & Diabetes Aspirin & Did you know as many as two out of three adults with Heart Health diabetes have high blood pressure? High blood pressure Studies have shown is a serious problem. It can raise your chances of stroke, that taking a low- heart attack, eye problems, and kidney disease. dose aspirin every Many people do not know they have high blood pressure day can lower the because they do not have any symptoms. That is why it risk for heart attack is often called “the silent killer.” and stroke. The only way to know if you have high blood pressure is Aspirin can help to have it checked. If you have diabetes, you should those who are at high have your blood pressure checked every time you see risk of heart attack, the doctor. People with diabetes should try to keep their such as people who blood pressure lower than 130 over 80. have diabetes or high blood pressure. Cholesterol & Diabetes Aspirin can also help Keeping your cholesterol and other blood fats, called lipids, under control can people with diabetes help you prevent diabetes problems. Cholesterol and blood lipids that are too who have already high can lead to heart attack and stroke. Many people with diabetes have had a heart attack or problems with their cholesterol and other lipid levels. a stroke, or who have heart disease. You will not know that your cholesterol and blood lipids are at dangerous levels unless you have a blood test to have them checked. Everyone with diabetes Taking an aspirin a should have cholesterol and other lipid levels checked at least once per year. -
Venous Thromboembolism: Lifetime Risk and Novel Risk Factors A
Venous Thromboembolism: Lifetime risk and novel risk factors A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Elizabeth Jean Bell, M.P.H. IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY Adviser: Aaron R. Folsom, M.D., M.P.H. March 2015 © Elizabeth Jean Bell 2015 ACKNOWLEDGEMENTS This research was supported by a training grant in cardiovascular disease epidemiology and prevention, funded by the National Institutes of Health. This fellowship has significantly enhanced my doctoral training experience. I could not have completed this research without the support of a great many people. I would first like to thank my advisor, Aaron Folsom. Thank you for taking me on as a mentee, not only at the doctorate level, but also at the master’s level. Undoubtedly you were an influence in my choice to continue my education with a doctorate in the first place. I recognize and appreciate the countless hours you have spent teaching and guiding; thank you for your thorough comments, quick turnaround times, and for always challenging me to achieve. I have learned much from you, including a passion for research. A huge thank you to Pam Lutsey, who has served as an informal mentor to me throughout my master’s and doctorate programs. Thank you for a countless number of things, including guiding my data analyses back before I knew how to do data analyses, sharing your expertise on every paper I have led, and being a role model to aspire to. Thank you to Alvaro Alonso and Saonli Basu, who have each offered their expertise through serving on my doctoral committee. -
Major Clinical Considerations for Secondary Hypertension And
& Experim l e ca n i t in a l l C Journal of Clinical and Experimental C f a o r d l i a o Thevenard et al., J Clin Exp Cardiolog 2018, 9:11 n l o r g u y o Cardiology DOI: 10.4172/2155-9880.1000616 J ISSN: 2155-9880 Review Article Open Access Major Clinical Considerations for Secondary Hypertension and Treatment Challenges: Systematic Review Gabriela Thevenard1, Nathalia Bordin Dal-Prá1 and Idiberto José Zotarelli Filho2* 1Santa Casa de Misericordia Hospital, São Paulo, Brazil 2Department of scientific production, Street Ipiranga, São José do Rio Preto, São Paulo, Brazil *Corresponding author: Idiberto José Zotarelli Filho, Department of scientific production, Street Ipiranga, São José do Rio Preto, São Paulo, Brazil, Tel: +5517981666537; E-mail: [email protected] Received date: October 30, 2018; Accepted date: November 23, 2018; Published date: November 30, 2018 Copyright: ©2018 Thevenard G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Introduction: In this context, secondary arterial hypertension (SH) is defined as an increase in systemic arterial pressure (SAP) due to an identifiable cause. Only 5 to 10% of patients suffering from hypertension have a secondary form, while the vast majorities have essential hypertension. Objective: This study aimed to describe, through a systematic review, the main considerations on secondary hypertension, presenting its clinical data and main causes, as well as presenting the types of treatments according to the literary results. -
Pulmonary Embolism Caused by Ovarian Vein Thrombosis During Cesarean Section: a Case Report
Oda et al. JA Clinical Reports (2018) 4:3 DOI 10.1186/s40981-017-0142-1 CASEREPORT Open Access Pulmonary embolism caused by ovarian vein thrombosis during cesarean section: a case report Yutaka Oda1* , Michie Fujita2, Chika Motohisa3, Shinichi Nakata3, Motoko Shimada1 and Ryushi Komatsu4 Abstract Background: Ovarian vein thrombosis is a rare complication of pregnancy. The representative complaints of patients with ovarian vein thrombosis are abdominal pain and fever. In some cases, however, fatal pulmonary embolism may develop. We report a case of pulmonary embolism presenting with severe hypotension and loss of consciousness during cesarean section possibly caused by ovarian vein thrombosis. Case presentation: A 25-year-old woman at 38 weeks 4 days of gestation was scheduled for repeat cesarean section. Her past history was unremarkable, and the progress of her pregnancy was uneventful. She did not experience any symptoms indicative of deep vein thrombosis. Cesarean section was performed under spinal anesthesia, and a healthy newborn was delivered. After removal of the placenta, she suddenly developed dyspnea, hypotension, and loss of consciousness with decreased peripheral oxygen saturation. Blood pressure, heart rate, and oxygen saturation recovered after tracheal intubation and mechanical ventilation with oxygen. Postoperative computed tomography revealed no abnormality in the brain or in the pulmonary artery, but a dilated right ovarian vein with thrombi, extending up to the inferior vena cava, was found. A diagnosis of pulmonary embolism caused by ovarian vein thrombosis was made, and heparin was administered. The tracheal tube was removed on the first postoperative day. Her postoperative course was uneventful, and she was discharged with no complications. -
Pulmonary Hypertension ______
Pulmonary Hypertension _________________________________________ What is it? High blood pressure in the arteries that supply the lungs is called pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The blood pressure measured by a cuff on your arm isn’t directly related to the pressure in your lungs. The blood vessels that supply the lungs constrict and their walls thicken, so they can’t carry as much blood. As in a kinked garden hose, pressure builds up and backs up. The heart works harder, trying to force the blood through. If the pressure is high enough, eventually the heart can’t keep up, and less blood can circulate through the lungs to pick up oxygen. Patients then become tired, dizzy and short of breath. If a pre-existing disease triggered the PH, doctors call it secondary pulmonary hypertension. That’s because it’s secondary to another problem, such as a left heart or lung disorder. However, congenital heart disease can cause PH that’s similar to PH when the cause isn’t known, i.e., idiopathic or unexplained pulmonary arterial hypertension. In this case, the PAH is considered pulmonary arterial hypertension associated with congenital heart disease, such as associated with a VSD or ASD (either repaired or unrepaired). The problem is due to scarring in the small arteries in the lung. It’s important to repair congenital heart problems (when possible) before permanent pulmonary hypertensive changes develop. Intracardiac left-to-right shunts (such as a ventricular or atrial septal defect, a hole in the wall between the two ventricles or atria) can cause too much blood flow through the lungs. -
Uncontrolled Hypertension and Associated Factors Among Hypertensive Adults in Bale Zone Public Hospitals, Ethiopia Feyissa Lemessa1* and Miressa Lamessa2
ISSN: 2474-3690 Lemessa and Lemessa. J Hypertens Manag 2021, 7:057 DOI: 10.23937/2474-3690/1510057 Volume 7 | Issue 1 Journal of Open Access Hypertension and Management ORIGINAL RESEARCH Uncontrolled Hypertension and Associated Factors among Hypertensive Adults in Bale Zone Public Hospitals, Ethiopia Feyissa Lemessa1* and Miressa Lamessa2 1 Department of Nursing, St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia Check for 2Department of Emergency and Critical Care, St. Paul’s Hospital Millennium Medical College, Addis Ababa, updates Ethiopia *Corresponding author: Feyissa Lemessa Jinfessa, Department of Nursing, St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, Tel : +251-920-405-878 Abstract Conclusion: The prevalence of uncontrolled hypertension was high at the study area among patients with hyperten- Background: Although blood pressure control has tremen- sion. Being overweight and lack of awareness on Hyperten- dous public health benefit, and has effective treatments, the sion i.e. poor knowledge on hypertension management can global rate of uncontrolled blood pressure remains high. In result in hypertension-related complications. Hence, Con- sub-Saharan Africa including Ethiopia uncontrolled blood tinuous health education on lifestyle practices and hyper- pressure resulted in a significant morbidity and mortality. tension-related complications in each follow-up visit highly Unfortunately, uncontrolled hypertension among adult hy- recommended. pertensive patients remains unclear and has been inade- quately studied in Ethiopia, in the study area in particular. Keywords Objective of the study: This study assessed uncontrolled Uncontrolled hypertension, Self-care practice, Bale, Ethiopia hypertension and associated factors among adult hyperten- sive patients on follow up clinics in Bale Zone Public Hospi- tals, Ethiopia, 2017. -
Hypertension and Hypotension
19/06/2018 Hypertension • Definitions: • WHO 140/90 • Westmead: calling criteria Hypertension and • If untreated 50% die of cardiovascular disease • 33% get a stroke Hypotension • 10% will develop renal failure Dr Giles Miller Hypertension • Causes • Essential • Renal • Endocrine • Neurogenic • Psychogenic • Miscellaneous 1 19/06/2018 Hypertension Hypertension treatments • Patterns • GTN patch • Hyperdynamic • Hydralazine • Vasoconstricted • B‐blockers • End Organ Damage • Ca channel • Cardiac • Diuretics • Eyes • ACEI • Renal • Angiotensin II blockers • Cerebral • Central acting alpha agonists Case Studies ‐ 1 Case 1 Needs to be reviewed but not a high priority • 78 yr old male • Past History • Admitted with UTI and delirium. Normally lives at home with • Mild dementia daughter as carer. • Hypertension ‐ Normally well controlled with BP 130/80 • Chronic renal failure (Cr 180) Always check the Medications! • Nurse calls you BP 168/92 at 10am on sat morning. • Medications • Diuretics, ACEI. • What are you going to do? • Missed daily dose of antiHT. 2 19/06/2018 Case Studies ‐ 2 Case 2 • Usual BP 150/90. • 56yr old lady with ESRF • On multiple antiHT • Dialysis 3 times a week via left AVF • ‐metoprolol, felodipine. • Had been drinking more recently due to some hot weather. Went • Nurse calls as BP prior to dialysis is 210/100 over usual fluid restriction. Weight up by 5kg You would always check with the renal physician/med reg first • What are you going to do? • Prazocin would be a typical drug to use in this circumstance Case Studies ‐ 3 Case 3 • Pre‐eclampsia definition: SBP >140, DBP >90 with renal involvement • Pregnant lady, 34 weeks. causing proteinuria. -
Pulmonary Hypertension Could Be a Risk for Deep Vein Thrombosis in Lower Extremities After Joint Replacement Surgery
Pulmonary hypertension could be a risk for deep vein thrombosis in lower extremities after joint replacement surgery Paerhati Rexiti1 Minawaer Wutiku2 Wuhuzi Wulamu1 FengZhou Bai1 Li Cao1 1. Department of Orthopaedics, The First Affiliation Hospital of Xinjiang Medical University, Urumqi, China. 2. Department of Sonography, Fourth Affiliated Hospital of Xinjiang Medical University, Urumqi, China. http://dx.doi.org/10.1590/1806-9282.65.7.946 SUMMARY A background of Pulmonary Hypertension (PH) indicates a progressive elevation of pulmonary vascular resistance, leading to overfilling, elevation of venous pressure, congestion in various organs, and edema in the venous system. This study aimed to investigate whether PH is a risk factor for deep vein thrombosis (DVT) of the lower extremities after hip and knee replacement surgery. METHODS: A total of 238 patients who received joint replacement of lower extremities in our department of orthopedics from January 2009 to January 2012 were examined by echocardiography and Color Doppler flow imaging (CDFI) of the lower extremities. Based on pulmonary artery pressure (PAP), the patients were divided into a normal PAP group (n=214) and PH group (n=24). All the patients were re-examined by CDFI during post-operative care. RESULTS: Among the 238 patients, 18 had DVT in the lower extremities after the operation. DVT total incidence rate was 7.56% (18/238). In the PH group, 11 patients had DVT (45.83%, 11/24), but in the normal PAP group, only 7 had DVT (3.27%, 7/214). The incidence of DVT was significantly lower in the normal PAP group than in the PH group (P<0.01).